SOTIO Biotech is shaping the future of cancer immunotherapies by translating compelling science into patient benefit. SOTIO’s robust clinical pipeline includes a next-generation PD-1-inhibiting cytokine, a proprietary technology designed to improve on the efficacy of CAR T therapies and a new generation of potent and stable antibody-drug conjugates (ADCs). SOTIO is a member of the PPF Group.
Company Details
- Employees
- 217
- Founded
- -
- Address
- Českomoravská 2532/19b, Prague 9,czech Republic 190 00,czech Republic
- Phone
- 420 224 175 111
- me****@****tio.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- sotio.com
- Keywords
- in cancer biology and therapeutic development. Explore our full pipeline: https://lnkd.in/d-UPGwb.
- HQ
- Prague 9, Czech Republic
Sotio Biotech Questions
Sotio Biotech's helpline number is 420 224 175 111
Sotio Biotech's website is sotio.com
Sotio Biotech's LinkedIn profile is https://www.linkedin.com/company/sotio
Sotio Biotech has
217 employees.
View email and phone details for 217
employees at Sotio Biotech.
Sotio Biotech's industry is
Biotechnology Research
Sotio Biotech's top competitors are
Diana Biotechnologies,
Zentiva,
Geneproof A.s.,
Sctbio,
Prague.bio,
Contipro,
Baria,
Enantis,
Exbio Praha, A.s.,
Generi Biotech S.r.o..
Sotio Biotech's support email address is media@sotio.com
Sotio Biotech's categories are Biotechnology Research
Sotio Biotech's founding year is 2010
